New hair serum shows promise in battle against balding
NCT ID NCT06556056
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study tested a new hair growth serum called SesZen-Bio against a standard treatment (minoxidil 1%) and a placebo in 108 adults with mild to moderate androgenic alopecia (male or female pattern baldness). Participants applied the serum daily to their scalp for several weeks. Researchers measured changes in hair thickness, density, and growth rate using a special imaging device. The goal was to see if the new serum is safe and effective for treating hair loss.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- SesZen-Bio Serum (topical) and Minoxidil 1% serum (topical)
- What this could lead to
- If it works, this could offer a new topical option for people with mild to moderate hair loss, potentially with fewer side effects than standard treatments.
- What could go wrong
- This is a small, early-stage study (108 people) with no phase designation. Results may not apply to everyone, and the new serum may not outperform existing options like minoxidil.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
108 people
The number who actually took part.
- Started
-
Jun 2024
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age: 25 to 45 years and above (both inclusive) at the time of consent. 2. Sex: Males and non-pregnant/non-lactating females (preferably equal number of males and females). 3. Females of childbearing potential must have a self-reported negative urine pregnancy. 4. Subject is in good general health as determined by the Investigator on the basis of medical history. 5. Patients having mild to moderate androgenic alopecia (Grade I to III) during clinical study and grade will be evaluated by the dermatologist by using Norwood-Hamilton classification and Ludwig pattern scale for female. 6. Female with 40-50 counts and male with 25 -30 counts of hair fall at screening. 7. Subject is able to remain on stable doses of contraceptive or replacement hormonal therapy, including no therapy, 6 weeks prior to and for the duration of the study. 8. If the subject is of childbearing potential, is practicing and agrees to maintain an established method of birth control (IUD, hormonal implant device/injection, regular use of birth control pills or patch, diaphragm, condoms with spermicide or sponge with spermicidal jelly, cream or foam, partner vasectomy or abstinence). Females will be considered as non-childbearing potential if they are surgically sterile, have been post-menopausal for at least 1 year or have had a tubal ligation. 9. Patients are willing to give written informed consent and are willing to follow the study procedure. 10. Patients who commit not to use any other medicated/ prescription shampoos/hair care products (containing Minoxidil), any other hair growth products or hair colour or dye, other than the test products for the entire duration of the study. 11. Willing to use test products throughout the study period. 12. Subject is willing and able to follow and allow study staff to performed study test methods. 13. Subject is willing and able to follow the study directions, to participate in the study, returning for all specified visits. 14. Subject must be able to understand and provide written informed consent to participate in the study. Exclusion Criteria: 1. Subject have history of severe hair fall due to any clinically significant problems like anaemia, thyroid problems. 2. Subject have history of any dermatological condition of the scalp other than hair loss and dandruff. 3. Subject have history of any prior hair growth procedures (e.g. hair transplant or laser). 4. Subject who had taken topical treatment of hair loss for at least 4 weeks. 5. Subject who had taken any systemic treatment for at least 3 months. 6. History of alcohol or drug addiction. 7. Subject having history or resent condition of irritated or visibly inflamed scalp or severe scalp disease. 8. Subject having history or present condition of an allergic response to any cosmetic products, any other condition which could warrant exclusion from the study. 9. Pregnant or breast feeding or planning to become pregnant during the study period. 10. History of chronic illness which may influence the cutaneous state. 11. Subject have participated any clinical research study related to hair care products. 12. Subject have history of mastectomy for cancer involving removal of lymph nodes within the past year, or treatment of any type of cancer within the last 6 months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Androgenic alopecia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NovoBliss Research Private Limited
Ahmedabad, Gujarat, 382481, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a serum plus a red light cap regrow hair?
- Can grape seed and green tea extracts turn the tide on baldness?
- Can a daily capsule thicken thinning hair? a trial puts three doses to the test
- Gummy bears for baldness? new study tests sweet solution
- Laser light shows promise for thinning hair in new trial
- Can tiny needles regrow hair? new study aims to find out